Aventura Private Wealth’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.89M Buy
4,078
+190
+5% +$194K 1.5% 11
2026
Q1
$3.58M Buy
3,888
+27
+0.7% +$27.4K 1.31% 14
2025
Q4
$4.15M Sell
3,861
-90
-2% -$86.1K 1.49% 11
2025
Q3
$3.01M Buy
3,951
+827
+26% +$615K 1.11% 13
2025
Q2
$2.44M Buy
3,124
+860
+38% +$668K 1.05% 12
2025
Q1
$1.87M Buy
2,264
+306
+16% +$255K 0.98% 15
2024
Q4
$1.51M Buy
+1,958
New +$1.62M 0.81% 22

Other funds holding LLY

Aventura Private Wealth's LLY Position: Q2 2026 in Review

Aventura Private Wealth increased its Eli Lilly (LLY) stake by 4.9% in Q2 2026, buying an estimated $194K and bringing the position to 4,078 shares worth $4.89M. The position accounts for 1.5% of the portfolio, ranked #11.

Aventura Private Wealth first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Aventura Private Wealth held 4,078 shares of Eli Lilly worth $4.89M as of Q2 2026.
  • Aventura Private Wealth bought 190 Eli Lilly shares in Q2 2026, an estimated $194K.
  • Eli Lilly made up 1.5% of Aventura Private Wealth's portfolio in Q2 2026, its #11 holding.
  • Aventura Private Wealth first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Aventura Private Wealth's 13F filing for Q2 2026, filed 15 Jul 2026.